Governor Hogan Celebrates Grand Opening of Paragon Bioservices’ Biomanufacturing Facility

Company Expects to Grow to More Than 500 Employees by End of 2019

(ANNAPOLIS, MD – April 11, 2019) Governor Larry Hogan today celebrated the grand opening of Paragon Bioservices’ new 200,000-square-foot, cutting-edge biomanufacturing facility near Baltimore/Washington Thurgood Marshall International Airport. The governor was joined by Department of Commerce Secretary Kelly M. Schulz, Anne Arundel County Executive Steuart Pittman, President and CEO Paragon BioServices Peter Buzy, and regional biotechnology industry leaders.

“We are experiencing an incredible economic resurgence, and one of the highlights is seeing homegrown Maryland businesses like Paragon Bioservices continue to invest and expand their footprint right here in our state,” said Governor Hogan. “We are pleased to support the continued growth of this incredible company and their remarkable life-saving work through the More Jobs for Marylanders program. Our state is proud to have a global reputation as a leading force in biohealth innovations, and today is further proof that we are just getting started.”

With this new facility and its operations at the University of Maryland BioPark in Baltimore, the company anticipates growing to more than 500 employees by the end of 2019. This new facility will specialize in clinical and commercial gene therapy manufacturing. Paragon contracts with many leading gene-therapy biopharmaceutical companies to develop and manufacture their products.

“We’re very proud of the fact that Paragon is a home-grown Maryland success story, and at every stage of its growth, the company has found the resources it needed right here,” said Secretary Schulz. “Paragon’s success confirms that Maryland is a great and welcoming place to do business, has the assets and resources companies need to thrive, and has a state government that stands ready to support and incentivize businesses that make such valuable contributions to Maryland’s economy.”

Founded in Baltimore nearly 30 years ago, Paragon is one of the largest and fastest-growing biotechnology companies in the state.